Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution... – Containing or obtained from compositeae
Reexamination Certificate
2003-12-23
2008-08-05
Flood, Michele (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
Containing or obtained from compositeae
Reexamination Certificate
active
07407675
ABSTRACT:
The present invention provides a composition for use in treating or preventing neoplasia, comprising an effective actein. The present invention also provides a composition for use in treating or preventing neoplasia, comprising an effective anti-neoplastic amount of an ethyl acetate extract of black cohosh. The present invention further provides a combination of anti-neoplastic agents, comprising an effective anti-neoplastic amount of an ethyl acetate extract of black cohosh and an effective anti-neoplastic amount of at least one additional chemopreventive or chemotherapeutic agent. Methods for treating and preventing neoplasia are also provided.
REFERENCES:
patent: 5972986 (1999-10-01), Seibert et al.
patent: 09030977 (1997-02-01), None
Bedir, E. et al., Chem. Pharm. Bull. (2000), 48(3): 425-427. Cimiracemoside A: A new cycloanostanol xyloside from the rhizome ofCimicifuga racemosa.
Corsano, S. Corsi e Seminari di Chimica, Consiglio Nazionale delle Ricerche e Fondazione F. Giordani (1968), 11, 61-4. Structure of the glucoside acetin.
http://www.holistic-online.com/Herbal-Med/—Herbs/h32.htm.
Gura, T. Science, 1997, 278:1041-1042. Systems for identifying new drugs are often faulty.
Jain, R. K. Sci. Am., 1994, 271:58-65. Barriers to drug delivery in solid tumors.
Curti, B. D. Crit. Rev. in Oncology/Hematology, 1993, 14:29-39. Physical barriers to drug delivery in tumors.
Beers and Berkow, eds., The Merck Manual of Diagnosis and Therapy, 17th ed. (Whitehouse Station, N. J. : Merck Research Laboratories, 1999). 973-974, 976, 986, 988, 991.
Bodinet and Freudenstein, Influence ofCimicifuga racemosaon the proliferation of estrogen receptor-positive human breast cancer cells. Breast Cancer Research and Trearment, 76:1-10, 2002.
Burdette, et al., Black cohosh (Cimicifuga racemosaL.) protects against menadione-induced DNA damage through scavenging of reactive oxygen species: bioassay-directed isolation and characterization of active principles. J. Agric. Food Chem., 50: 7022-7028, 2002.
Chen et al., Isolation, structure elucidation, and absolute configuration of 26-deoxyactein fromCimicifuga racemosaand clarification of nomenclature associated with 27-deoxyactein. J. Nat. Prod., 65: 601-605, 2002.
Chou and Talalay, Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul., 22: 27-55, 1984.
Dixon-Shanies and Shaikh, Growth inhibition of human breast cancer cells by herbs and phytoestrogens. Oncol. Rep., 6: 1383-1387, 1999.
Foster, S., Black cohosh:Cimicifuga racemosa. A literature review. HerbalGram, 45: 35-49, 1999.
Fulda and Debatin, Betulinic acid induces apoptosis through a direct effect on mitochondria in neuroectodermal tumors. Med. Pediatr. Oncol., 35: 616-618, 2000.
Hall et al., The fractional inhibitory concentration (FIC) index as a measure of synergy. J. Antimicrob. Chemother., 11(5): 427-433, 1983.
Han et al., Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth. Oncogene, 10: 953-961, 1995.
Han et al., Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines. Breast Cancer Res. Treat., 48: 195-203, 1998.
Haridas et al., Avicins: triterpenoid saponins fromAcacia victoriae(Bentham) induce apoptosis by mitochondrial perturbation. Proc. Natl. Acad. Sci. USA, 98: 5821-5826, 2001.
Ito et al., The novel triterpenoid CDDO induces apoptosis and differentiation of human osterosarcoma cells by a caspase-8 dependent mechanism. Mol. Pharmacol., 5: 1094-1099, 2001.
Joe et al., Cyclin D1 overexpression is more prevalent in non-Caucasian breast cancer. Anticancer Res., 21: 3535-3539, 2001.
Joe et al., Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin. Cancer Res., 8: 893-903, 2002.
Kruse et al., Fukic and piscidic acid esters from the rhizome ofCimicifuga racemosaand the in vitro estrogenic activity of fukinolic acid. Planta. med., 65: 763-764, 1999.
Lehmann-Willenbrock and Riedel, Clinical and endocrinologic studies of the treatment of ovarian insufficiency manifestations following hysterectomy with intact adnexa. Zent. BI. Gynakol., 110: 611-618, 1988.
Lim et al., Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines. Biochem. Pharmacol., 58: 1097-1107, 1999.
Loser et al., Inhibition of neutrophil elastase activity by cinnamic acid derivatives fromCimicifuga racemosa. Planta. Med., 66: 751-753, 2000.
Luo et al., PM-3, a benzo-g-pyran derivative isolated from propolis, inhibits growth of MCF-7 human breast cancer cells. Anticancer Res. 21: 1665-1672, 2001.
Masuda et al., Effects of epigallocatechin-3-gallafate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clinical Cancer Research, 7: 4220-4229, 2001.
Masuda et al., Epigallocatechin-3-gallate inhibits activation of HER-2
eu and downstream signaling pathways in human head and neck and breast carcinoma cells. Clin. Cancer Res., 9: 3486-3491, 2003.
Meiers et al., The anthocyanidins cyaniding and delphindin are potent inhibitors of the epidermal growth-factor receptor. J. Agric. Food Chem., 49: 958-962, 2001.
Nesselhut et al., Studies on mammary carcinoma cells regarding the proliferation potential of herbal medication with estrogen-like effects. Archives of Gynecology and Obstetrics, 254: 817-818, 1993.
Pedersen et al., The triterpenoid CDDO induces apoptosis in refractory CLL B cells. Blood, 8: 2965-2972, 2002.
Pisha et al., Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat. Med., 1: 1046-1051, 1995.
Sakurai et al., Antitumor agents 220. Antitumor-promoting effects of cimigenol and related compounds on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis. Bioorg. Med. Chem. 11: 1137-1140, 2003.
Sgambato et al., Overexpression of p27 (Kip1) inhibits the growth of both normal and transformed human mammary epithelial cells. Cancer Research, 58: 3448-3454, 1998.
Soh et al., Novel roles of specific isoforms of protein kinase C in activation of the c-fos serum response element. Molecular and Cellular Biology, 19: 1313-1324, 1999.
Soh et al., Cyclic GMP mediates apoptosis induced by sulindac derivatives via activation of c-Jun NH2-terminal kinase 1. Clin. Cancer Res., 10: 4136-4141, 2000.
Soriano et al., Synergistic effects of new chemoprotective agents and conventional cytotoxic agents against human lung cancer cell lines. Cancer Res., 59: 61, 78-84, 1999.
Sporn and Suh, Chemoprevention of Cancer. Carcinogenesis, 21: 525-530, 2000.
Stadheim et al., The novel triterpenoid 2-cyano-3,12-dioxooleana-1, 9-dien-28-oic acid (CDDO) potently enhances apoptosis induced by tumor necrosis factor in human leukemia cells. J. Biol. Chem., 19: 16448-16455, 2002.
Stoll, W., Phytotherapy influences atrophic vaginal epithelium: double-blind study—cimicifuga vs. estrogenic substances. Therapeuticum, 1: 23-31, 1987.
Suh et al., Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages. Cancer Res., 58: 717-723, 1998.
Suh et al., A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity. Cancer Res., 59: 336-341, 1999.
Suzui et al., Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21 (CIP1) and inhibition of expression of cyclin D1. Cancer Research, 62: 3997-4006, 2002.
Tsutsui et al., Prognostic value of c-erbB2 expression in breast cancer. J. Surg. Oncol., 79:216-233, 2002.
Wang et al., A synthetic triterpenoid, 2-cyano-2,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferators-activated receptor gamma. Mol. Endocrinol., 14: 1550-1556, 2000.
Watanabe et al., Cycloartane glycosid
Einbond Linda Saxe
Weinstein I. Bernard
Bryan Cave LLP
Flood Michele
The Trustees of Columbia University in the City of New York
LandOfFree
Anti-neoplastic compositions comprising extracts of black... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-neoplastic compositions comprising extracts of black..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-neoplastic compositions comprising extracts of black... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4015967